of certain enzymes in the cerebrospinal fluid (CSF)4 reportedly increase by diagnostically significant amounts in a number of conditions. In contrast to benign cerebral tumors, malignant primary cerebral metastases are frequently accompanied by increased AST and LD activity in the lumbar CSF (1) (2) (3) (4) (5) . Similar changes help to distinguish benign from malignant spinal cord lesions (5). Normal 'CSF LD activity in the presence of increased AST has been reported as an invariable feature of the neuromyopathy associated with noncerebral carcinomatous lesions (6).
Abnormally high activities of AST and LD in the CSF in cases of bacterial meningitis aid in discriminating this condition from viral infections of the central nervous system, in which these activities are generally normal or only slightly increased (7-10); moreover, in the former, AST assays have been reported to be of greater prognostic significance than conventional chemical data on CSF (11) . Prognostic importance also attaches to CSF activities of AST and LD after head injury, because concussion is associated with normal values, contusion with abnormally high values that increase in proportion to the extent of the brain damage (12, 13) .
Estimates of MD activity in CSF have been less frequently reported. However, increased values have been described in cases of cerebral tumor (14) , and were recorded more often than increased values for AST and LD when corrected for age in a large series of patients with various neurologic disorders (15). Activities of this enzyme are greater than those of LD in brain tissue, and the two enzymes vary in distribution in different regions of the brain (16) This investigation was therefore undertaken to study the requirements for optimal determination of three enzymes in CSF preliminary to adapting the optical kinetic assays concerned for use with automatic reaction-rate monitors. Reference values are also reported for these techniques based on analyses conducted on patients in whom increased activities would not be expected.
Materials and Methods
CSF obtained by lumbar puncture was stored at -20#{176}C until analyzed 2 to 10 weeks later, after removing a portion for routine chemical, bacteriologic, and cytologic investigations. Xanthochromic fluids and those visibly contaminated with blood were rejected. Samples were thawed in batches of 10 to 20, and estimated without delay for activities of AST, LD, and MD.
All chemicals used were of purest analytical grade and all water was glass-distilled and de-ionized. 
Chemistry of Enzyme Reactions
All were followed by measuring the rate of decrease in the absorbance at 340 nm consequent upon oxidation of NADH. AST was measured in the conventional coupled optical assay introduced by Karmen (17) : The true activity owing to MD was obtained by subtracting a "control" in which all constituents except CSF were present (equivalent to 3b + 3c) from a "test" (equivalent to 3a + 3b + 3c). This "control," in reality a reagent blank, was run in the first and tenth positions of each ten-space cuvet block, and the average of the two estimates was subtracted from the values obtained for the intervening eight tests. CSF itself gave no reaction in the absence of oxaloacetate in this assay system.
Procedures
These are summarized in Table 1 . Because other enzymes are included in the reaction mixtures, scrupulous care must be taken to avoid contamination, and the order of assay should be first LD, second MD (because the reaction mixture contains LD), and finally AST (because the reaction mixture contains MD).
Racks of polystyrene cuvets were filled with sample and all constituents of the reaction mixture (except for the initiating substrate) by use of an "AutoDilutor" (Hook and Tucker Instruments Ltd., London, England). The cuvets were transferred manually to the "8600 Reaction Rate Analyser" (LKB Instruments, Bromma, Sweden), after which all operations proceeded automatically in a predetermined manner.
The cuvets were warmed to 37#{176}C in the heating tunnel (only this temperature was used in all the work described here) and then passed into the light path. Substrate was injected, the contents were (lb) mixed, the absorbance at 340 nm was recorded, and backed off to zero time. Subsequent change in A340 was presented as a linear trace on an external "slave" recorder (Philips PM 8000). Full-scale deflection on the recorder was equivalent to .A50 = 0.050 for AST and LD assays, but if this was exceeded during the time selected to monitor the reaction in each cuvet, the full-scale deflection was automatically adjusted to #{163}4340= 0.200 for the remainder of the measuring period, on completion of which the old cuvet was moved towards the exit tunnel and a fresh cuvet entered the light path. This process was self-repeating until such time as all cuvets placed on the loading tray had been dealt with. The recorder paper was then removed and enzyme activity was read by applying to the progress curve of the reaction a transparent plastic template calibrated in International Units (U) per liter. The calibration took account of the sample dilution and total reaction volume inherent in the methods used for each enzyme according to the protocols set out in Table 1 . The use of this instrumental system has been described and evaluated (21-23). It was used in all the clinical work reported in this paper. However, in carrying out the experiments to establish the definitive procedures, we used the reagents described in Table 1 in the same proportions in a final total volume of 3 ml, and we also used the SP 800 double-beam spectrophotometer (Pye Unicam Instruments Ltd., Cambridge, England), with a number of work-simplication accessories (24), to record the initial 1.5mm of the enzyme reaction.
Results and Discussion

Validation of Methods
The assay of MD activity of CSF was based upon a previously-published method (20), in which this specific material was used, as well as certain other sources of MD activity. The optimum requirements for determination of CSF activity of AST and LD have not been systematically determined, previous authors having chosen to use conditions that were originally presented for use with serum or tissues. We therefore examined these aspects in some detail, with the following results:
A plateau between pH 7.0-7.6 was obtained for AST with 0.1 molar phosphate buffer (Figure 1 ). For LD, however, a definite peak at pH 7.2 was obtained with this buffer.
Buffer molarity. Studies with phosphate buffer showed that for both AST and LD, 0.1 molar was optimal. The results ( Figure 2 ) were similar to those obtained at two other pH valUes in the range 7.0-7.8.
Buffer anion. Ten buffers were evaluated. Figure 4 demonstrates the effect of changing the concentration of each substrate with the remaining constituents fixed at the single concentration used in the definitive procedure.
Methodological Features
Linearity. This could not be tested with lumbar CSF because of the relatively low enzyme activity encountered.
We therefore used CSF obtained by cisternal puncture of fresh human cadavers in this work and that described in the next two sections. For all three enzymes, dilution of a high-activity pool in 0.15 molar NaC1 showed that #{163}4340over the first minute of the reaction was proportional to the amount of CSF that was used, up to a value of at least 0.150, corresponding to about 150 U/liter with the LKB 8600. Whereas for AST and LD this represented true enzyme activity, in the case of MD this represented the value for "test + control," so that for this enzyme true activities in excess of 120 U/ liter had to be re-assayed after dilution of the sample.
Precision. Studies in which cisternal CSF was used and having bearing upon this question are reported in Table 3 .
Stability.
Once constituted, the reaction mixture less initiating substrate was stable for up to 2 h at room temperature and up to 6 h at 4#{176}C. When CSF was added to this mixture, no loss of activity oc- curred up to 1 h at room temperature, but a steady decrease of 10% per hour occurred thereafter. The initiating substrates, 2-oxoglutarate and pyruvate, gave constant results when held at room temperature for up to 2 h. Moreover, they could be stored for up to six months at -20#{176}C as small aliquots, these being discarded on completion of the batch for which they were unfrozen.
Oxaloacetate, by contrast, was highly unstable.
It must be made up immediately before use, stored in a dark bottle on ice, and not used for more than 20 consecutive assays unless the MD control value remains at acceptable levels. Table 4 presents data on the stability of the three enzymes in CSF. The losses at 20#{176}C and 4#{176}C were gradual, but those at -20#{176}C were a function of the freezing and thawing process, and storage for up to three months did not cause further loss. Once thawed, the samples were less stable at 20#{176}C and at 4#{176}C than fresh samples, so that the analyses should then be completed without undue delay.
Temperature Dependence
Enzyme activities were measured in four samples at five temperatures, ranging from 20#{176}C to 40#{176}C. The actual cuvet temperatures were recorded to ±0.1#{176}C and were controlled by an external circulating waterbath guaranteed to maintain temperature constant to ±0.1#{176}C over the range studied. Utilizing the conventional form of the Arrhenius equation:
and using saturating concentrations of substrates to approximate Vm0x, we plotted log velocity against reciprocal of absolute temperature ( Figure 5 ) and de- were as follows: 10.5 kcal for AST (range, 9.6 to 11.4), 12.2 kcal for LD (range, 11.2 to 13.5), and 13.6 kcal for MD (range, 13.4 to 13.8).
Data on Clinical Groups
The values obtained in patients free of organic CNS disease and in those with cervical spondylosis lacking evidence of myelopathy, together with those in disease categories designated as "degenerative," are presented in Table 5 . The latter are not among those giving rise to elevated CSF enzyme activities according to the literature cited in the Introduction. Since the main clinical value of these determinations 7.5 ± 3.4
8.8 ± 4.0 8.4 ± 2.6 6.9 ± 2.5 9.1 ± 3.9
8.7 ± 4.0 to extract from all of the data in Table 5 a set of referendary values that can be used to assess the significance of the activities in individual subjects representing a genuine diagnostic problem. For this purpose the 97.5-percentile limit based upon statistical treatment of the total data according to Hoffmann (32) seems appropriate.
This approach to the problem of reference values is being increasingly advocated (33, 34) . The cumulative frequency distribution for each enzyme was plotted on normal probability paper and the central (linear) portion was extrapolated to intersect the 97.5-percentile horizontal line; a perpendicular was then dropped to the abscissa and the value for enzyme activity recorded. On this basis, reference limits were established at 13.5 U for AST, 40 U for LD, and 58 U for MD.
Using the parametric t-test, we found no significant difference between the means of the nonorganic and degenerative groups for any of the three enzymes. Neither did their distributions as assessed by the nonparametric Mann-Whitney U-test (35) differ significantly, although inspection of the distributions showed that for AST and LD there was a longer tail of high "outliers" in the degenerative group. However, the influence of these "outliers" was minimized by the statistical treatment we adopted (32). There was no difference between the mean values for men and women for any of the enzymes studied. On regression analysis between age of subject and enzyme activity, an r of 0.203 (P <0.025) was obtained for AST, but for LD and MD the correlation with age and the parameters of the regression equation were not significant. This is at variance with reports claiming a close relationship between age and CSF activities of AST and LD in both normal subjects (15) and patients with neurologic disease (36). Others have been unable to obtain a correlation between age and CSF activity of AST (37).
It has been reported that AST and LD are significantly correlated with the protein concentration of the CSF (36) and also that no such correlation exists (6). We cannot resolve this controversy, since all the subjects of Table 5 had normal values for CSF protein, and the assay, which was done in another laboratory outside our control, is not in our view reliable within this range. Data from patients excluded from our reference group are presented in Table 6 . Values in cases of epilepsy were not outside our reference limits, although increases have been reported in such subjects (4, 15, 38) . The apparently low mean AST was just outside the limit of statistical significance.
In cases with cervical spondylosis associated with myelopathy the mean MD activity was significantly increased (P <0.005). The mean AST activity in our patients with encephalitis was significantly decreased (P <0.025) and this was also true of the entire group of subjects with multiple sclerosis (P <0.05). Diminished activity of AST in the CSF in cases of multiple sclerosis has previously been described (36), although most authors report normal CSF enzyme activities in this condition (6, 39, 40) . No data for tumors, cerebrovascular accidents, or meningitis are included, because we are making a detailed study of these conditions and our numbers at present are inadequate. Table 7 presents results of serial assays in subjects who required lumbar puncture on more than one occasion. The results are for the most part reproducible in the same subject. Because it has been stated that air encephalography increases CSF enzymes (41), no fluid obtained during this procedure has been included in our data previously in this paper. However, Table 8 presents results obtained in two patients during the course of air encephalography.
Mter injection of as much as 12 ml of air, no consistent change was observed. Beyond that, there seemed to be an increase in LD and MD activities in one subject.
We conclude that the enzyme activity in human 
35
CSF, being much less than that of normal human blood serum, poses special analytical problems. Moreover, "normal" and "greatly elevated" activities as defined by previous workers (1-15) fall well within the range encountered in normal serum; the difference between a "normal" and a "slightly increased" value is almost within the analytical variance of most methods. CSF enzymes are less stable than are their counterparts in serum. As compared to venepuncture, only a limited volume of CSF may be withdrawn at a time without danger to the patient, and the procedure for obtaining this material, being unpleasant and potentially hazardous, should not be repeated unnecessarily.
Thus, few determinations place a greater burden of responsibility upon the analyst to provide accurate and precise results. These problems have largely been ignored in the past, and methods for estimating serum enzymes have been adopted without regard to their suitability. Although we have obtained evidence for the kinetic similarity of serum and CSF enzymes (31), (10, (42) (43) (44) . The methods presented in this paper are based upon rigorous consideration of the properties of CSF enzymes. They utilize the principles of kinetic assays, call for the minimum of manipulative intervention by the analyst, permit the processing of large sample batches semi-automatically with adequate quality control, and provide reasonable precision at low enzyme activities. Their use may be expected to exploit in the most refined manner the diagnostic potential claimed for these assays.
